Patient portal myth-busting

Will patient access to a portal improve satisfaction? Will older patients use the portal? How about portal security?

These are all questions faced by providers as patient portals gather steam. In an effort to bust some myths related to the use of portals, Rochester, N.Y.-based Carestream commissioned a market consultancy firm to survey patients about portal usage. Some of the findings can be seen in this infographic provided by Carestream:

[[{"fid":"17984","view_mode":"media_original","type":"media","attributes":{"height":3076,"width":792,"style":"width: 460px; height: 1787px;","alt":" - carestream infographic mythbuster patient portal","class":"media-element file-media-original"}}]]

Around the web

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.